UMass Medical School’s Clinical Pharmacy Services offers comprehensive prescription drug management services to state and federal agencies, pharmacy benefit managers, managed care organizations, and correctional health programs. First established in 1999 to provide drug utilization review services for Massachusetts Medicaid, we have become an industry leader in both service delivery and consultancy. As a division of UMass Medical School, Clinical Pharmacy Services is in the unique position to benefit from the clinical and research resources of one of the nation’s leading academic health science centers. This collection showcases publications and presentations written by Clinical Pharmacy Services staff.

Follow

Publications from 2009

Link

Panitumumab-Related Hypomagnesemia in Patients With Colorectal Cancer, Haiying Cheng, David C. Gammon, Traci M. Dutton, and Bilal Piperdi

Link

Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in the treatment of peritoneal carcinomatosis, David C. Gammon, Traci M. Dutton, Bilal Piperdi, Jason Zybert, Steven H. Wolfe, Erin Nguyen, Dalia Sbat, Venu G. Pillarisetty, Mary E. Sullivan, and Giles F. Whalen

Publications from 2008

Link

Managing reduced methotrexate clearance in a patient with a heterozygous methylenetetrahydrofolate reductase gene polymorphism, David C. Gammon, Mansi S. Bhatt, Bhavini Patel, Meghan Anderson, Alixis Van Horn, and Michael J. Glantz

Link

A successful veno-occlusive disease (VOD) prophylaxis strategy for patients undergoing stem cell transplantation, David C. Gammon, Kristi Holt, Traci M. Dutton, Janet Rogers, and Samer Al-Homsi

Link

Intraurethral fluorouracil and lidocaine for intraurethral condyloma acuminata, David C. Gammon, Keith A. Reed, Mausaum Patel, and Kethandapatti Balaji

Publications from 2006

Link

Intrathecal topotecan in adult patients with neoplastic meningitis, David C. Gammon, Mansi S. Bhatt, Lan Tran, Alexis Van Horn, Matthew Benvenuti, and Michael J. Glantz

Link

Reduced-dose rasburicase in the treatment of adults with hyperuricemia associated with malignancy, Donald A. Hutcherson, David C. Gammon, Mansi S. Bhatt, and Melissa Faneuf

Publications from 2004

Link

Safety and cost-effectiveness of paclitaxel administered as a 1-hour infusion versus a 3-hour infusion for various malignancies, David C. Gammon and Margaret W. Lizotte

Link

Superselective Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: Experience with a New Emulsion., David C. Gammon, Sekhar Rao, Ducksoo Kim, Pankaj Bhargava, and Timothy R. Bartlett

Publications from 2003

Link

Hypersensitivity and idiosyncratic reactions to oxaliplatin, Pankaj Bhargava, David C. Gammon, and Michael J. McCormick

Link

Zoledronic Acid vs Pamidronate for the Prevention of Hypercalcemia of Malignancy or Bone Metastases in Hospital Outpatients: Time Analysis and Economic Implications., David C. Gammon and Hoang T. Le

Publications from 1997

Link

Preventing Errors With Antineoplastic Agents: A Pharmacist's Approach., Donald A. Hutcherson and David C. Gammon